Rapid Micro Biosystems, Inc.
RPID
$2.22
$0.020.91%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 37.28% | 3.08% | 9.73% | 28.41% | 29.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.28% | 3.08% | 9.73% | 28.41% | 29.68% |
| Cost of Revenue | 60.43% | 2.29% | 2.64% | -4.67% | 11.18% |
| Gross Profit | -133.44% | 11.90% | 245.50% | 126.53% | 670.35% |
| SG&A Expenses | 10.95% | -5.67% | -2.67% | -5.24% | -10.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.35% | -2.20% | -2.93% | -5.12% | -0.42% |
| Operating Income | -19.38% | 5.54% | 9.19% | 18.30% | 16.07% |
| Income Before Tax | -29.02% | -1.65% | 5.70% | 15.49% | 13.34% |
| Income Tax Expenses | 255.56% | -38.46% | -26.67% | 133.33% | -212.50% |
| Earnings from Continuing Operations | -29.29% | -1.61% | 5.72% | 15.46% | 13.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.29% | -1.61% | 5.72% | 15.46% | 13.48% |
| EBIT | -19.38% | 5.54% | 9.19% | 18.30% | 16.07% |
| EBITDA | -22.84% | 5.43% | 9.59% | 19.55% | 16.97% |
| EPS Basic | -26.86% | 1.31% | 7.91% | 16.91% | 14.75% |
| Normalized Basic EPS | -26.56% | 1.30% | 7.89% | 16.94% | 14.53% |
| EPS Diluted | -26.86% | 1.31% | 7.91% | 16.91% | 14.75% |
| Normalized Diluted EPS | -26.56% | 1.30% | 7.89% | 16.94% | 14.53% |
| Average Basic Shares Outstanding | 1.94% | 2.95% | 2.37% | 1.73% | 1.46% |
| Average Diluted Shares Outstanding | 1.94% | 2.95% | 2.37% | 1.73% | 1.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |